MannKind Corp
MNKD
#5812
Rank
HK$9.83 B
Marketcap
HK$30.58
Share price
3.72%
Change (1 day)
-27.45%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2023 (TTM): -HK$1.49

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -HK$1.02. In 2022 the company made an earnings per share (EPS) of -HK$2.67 a decrease over its 2021 EPS that were of -HK$2.51.

EPS history for MannKind Corp from 2004 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$1.49-44.16%
2022-HK$2.676.25%
2021-HK$2.5128%
2020-HK$1.96-7.41%
2019-HK$2.12-55.74%
2018-HK$4.78-45.05%
2017-HK$8.70-188.1%
2016HK$9.88-128.31%
2015-HK$34.8974.51%
2014-HK$19.99-20.31%
2013-HK$25.09-32.63%
2012-HK$37.24-28.03%
2011-HK$51.75-12%
2010-HK$58.80-27.54%
2009-HK$81.15-30.3%
2008-HK$116.43-18.85%
2007-HK$143.48-19.03%
2006-HK$177.1956.94%
2005-HK$112.90-21.74%
2004-HK$144.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-684.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$31.97-3,236.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
HK$242.00-23,843.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.78-863.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$27.60-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-HK$23.21 2,176.92%๐Ÿ‡บ๐Ÿ‡ธ USA